EUROFINS CENTRAL LABORATORY
A member of the Eurofins group of over 800 laboratories, across 50 countries, with over 48,000 staff and a portfolio of over 200,000 validated analytical methods.
Eurofins is a pure-play leading Global Central Laboratory with extensive experience in Phases I‐IV clinical trials and works with top Pharma, biotech, and CROs to support drug development through laboratory testing, validation and assay development. We have the informational infrastructure, project and investigator support, analytical capabilities and experience to develop and run assays in CAP/CLIA and GCLP‐fit-for-purpose regulatory frameworks.
Eurofins operates its four wholly‐owned central laboratories in the US, Europe, Singapore and China under the same international quality standards, regulatory guidelines, SOPs and IT infrastructure globally. Eurofins has a broad range of equivalent testing capabilities, experience, leadership and dedicated staff, as well as harmonized standards and regulatory framework of its global sites, that strongly positions Eurofins to be a solid, dependable central lab partner for your clinical development programs.
Eurofins Central Laboratory is currently supporting clinical trials in nearly 85 countries across 6 continents. Our global footprint ensures optimum specimen integrity, timely turnaround of results, manageability of the logistic process and control over the associated costs.